Pharmacogenomic Profiling of Pediatric Patients

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Mental DisordersMetabolism Medication ToxicityPediatric Disorder
Trial Locations (1)

35233

Children's of Alabama, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT02770339 - Pharmacogenomic Profiling of Pediatric Patients | Biotech Hunter | Biotech Hunter